Viking Therapeutics, Inc. (FRA:1VT)
31.51
+0.65 (2.09%)
Last updated: Dec 1, 2025, 3:10 PM CET
Viking Therapeutics Employees
Viking Therapeutics had 36 employees as of December 31, 2024. The number of employees increased by 9 or 33.33% compared to the previous year.
Employees
36
Change (1Y)
9
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
€3,967,273
Market Cap
3.36B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 36 | 9 | 33.33% |
| Dec 31, 2023 | 27 | 6 | 28.57% |
| Dec 31, 2022 | 21 | 3 | 16.67% |
| Dec 31, 2021 | 18 | -2 | -10.00% |
| Dec 31, 2020 | 20 | 1 | 5.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Viking Therapeutics News
- 4 days ago - Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 - The Motley Fool
- 6 days ago - Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 9 days ago - 2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon - The Motley Fool
- 10 days ago - 3 Weight-Loss Drug Stocks To Consider For 2026 - Benzinga
- 10 days ago - Viking Therapeutics (VKTX) Up 1% Since Last Earnings Report: Can It Continue? - Nasdaq
- 10 days ago - 3 Mid-Cap Growth Stocks That Have Mammoth Long-Term Potential - The Motley Fool
- 11 days ago - VKTX Completes Enrollment in First Late-Stage Study on Obesity Drug - Nasdaq
- 12 days ago - Viking Therapeutics, Up 62% Since August, Lingers In Buy Zone On An Obesity Win - Investor's Business Daily